Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation

被引:149
作者
Sarmento, LM
Huang, H
Limon, A
Gordon, W
Fernandes, J
Tavares, MJ
Miele, L
Cardoso, AA
Classon, M
Carlesso, N [1 ]
机构
[1] Harvard Univ, Sch Med, Ctr Regenerat Med & Technol, Boston, MA 02129 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02129 USA
[4] Univ Lisbon, IMM, P-1649028 Lisbon, Portugal
[5] Sci Res Lab Inc, Somerville, MA 02143 USA
[6] Univ Illinois, Dept Pharmacodynam, Chicago, IL 60612 USA
关键词
D O I
10.1084/jem.20050559
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cyclin-dependent kinase inhibitors (CKIs) and Notch receptor activation have been shown to influence adult stem cells and progenitors by altering stem cell self-renewal and proliferation. Yet, no interaction between these molecular pathways has been defined. Here we show that ligand-independent and ligand-dependent activation of Notch1 induces transcription of the S phase kinase-associated protein 2 (SKP2), the F-box subunit of the ubiquitin-ligase complex SCFSKP2 that targets proteins for degradation. Up-regulation of SKP2 by Notch signaling enhances proteasome-mediated degradation of the CKIs, p27(Kip1) and p21(Cip1), and causes premature entry into S phase. Silencing of SKP2 by RNA interference in G(1) stabilizes p27(Kip1) and p21(Cip1) and abolishes Notch effect on G(1)-S progression. Thus, SKP2 serves to link Notch1 activation with the cell cycle machinery. This novel pathway involving Notch/SKP2/CKIs connects a cell surface receptor with proximate mediators of cell cycle activity, and suggests a mechanism by which a known physiologic mediator of cell fate determination interfaces with cell cycle control.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 45 条
[1]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[2]  
Aster JC, 1997, J BIOL CHEM, V272, P11336
[3]   Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34+CD38low/neg human bone marrow cells [J].
Bennaceur-Griscelli, A ;
Tourino, C ;
Izac, B ;
Vainchenker, W ;
Coulombel, L .
BLOOD, 1999, 94 (02) :529-538
[4]  
Berezikov E, 2000, GENOME BIOL, V1
[5]   Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells [J].
Bocchetta, M ;
Miele, L ;
Pass, HI ;
Carbone, M .
ONCOGENE, 2003, 22 (01) :81-89
[6]   Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase [J].
Bornstein, G ;
Bloom, J ;
Sitry-Shevah, D ;
Nakayama, K ;
Pagano, M ;
Hershko, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) :25752-25757
[7]   Osteoblastic cells regulate the haematopoietic stem cell niche [J].
Calvi, LM ;
Adams, GB ;
Weibrecht, KW ;
Weber, JM ;
Olson, DP ;
Knight, MC ;
Martin, RP ;
Schipani, E ;
Divieti, P ;
Bringhurst, FR ;
Milner, LA ;
Kronenberg, HM ;
Scadden, DT .
NATURE, 2003, 425 (6960) :841-846
[8]   Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics [J].
Carlesso, N ;
Aster, JC ;
Sklar, J ;
Scadden, DT .
BLOOD, 1999, 93 (03) :838-848
[9]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[10]  
Cereseto A, 2000, J CELL PHYSIOL, V185, P425, DOI 10.1002/1097-4652(200012)185:3<425::AID-JCP13>3.0.CO